Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong.
Sharen LeeJiandong ZhouKeith Sai Kit LeungAbraham Ka Chung WaiKamalan JeevaratnamEmma KingTong LiuWing Tak WongCarlin ChangIan Chi Kei WongBernard Man Yung CheungGary TseQingpeng ZhangPublished in: Cardiovascular drugs and therapy (2022)
Based on real-world data of type 2 diabetic patients in Hong Kong, SGLT2I use was associated with lower risk of incident AF, stroke/transient ischemic attack, and cardiovascular and all-cause mortality outcomes compared to DPP4I use.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- cerebral ischemia
- left atrial appendage
- direct oral anticoagulants
- heart failure
- cardiovascular disease
- percutaneous coronary intervention
- electronic health record
- type diabetes
- climate change
- subarachnoid hemorrhage
- machine learning
- coronary artery disease
- blood brain barrier
- risk assessment
- weight loss